View more on these topics

Schroder prescribes medicine for new fund

Schroder is kicking off the second Isa season with the launch of a global


healthcare fund and a European technology fund.


The medical discovery fund, supported by cancer research, aims to


capitalise on companies creating new advances in the field of medicine and


takeover activity in pharmaceutical stocks.


Half of any retained initial charge together with a percentage of the


annual management charge will be paid to cancer research.


Stocks in the portfolio will include the likes of Astra Zeneca and Johnson


& Jonhson.


The EuroTech fund will invest primarily in European technology companies,


including the UK.


The initial charge on both funds is 5.25 per cent and the annual


management charge is 1.5 per cent. Commission is 3 per cent and renewal is


0.5 per cent.


The EuroTech fund is available as a Pep transfer.


Client services director Robin Stoakley says: “The medical discovery fund


is not a biotech fund but will encompass a broader spectrum of medical


companies.


“We did not want to launch a global tech fund because emphasis would have


focused on US stocks which are not as attractive as European stocks.”



Royal & Sun Alliance Investments has launched a pan-European technology


fund investing in about 50 stocks made up of both small and large-cap


companies.

Recommended

Premium problem stops mortgage endowment plan

Bungle Busters comes to you courtesy of Legal & General for the secondweek in succession as we take up the case of David Ellis, a trainee withChelmsford-based IFA TK Jones.Ellis called BB after L&G consistently fouled up in accepting his premiumsfor a recently set-up mortgage endowment plan.Ellis bought the plan in February, with his first […]

Standard Life general…

Standard Life general sales manager Norman Arthur will be leaving his seatin the Scottish capital on his 60th birthday next month.He will be replaced by the Edinburgh life office&#39s current assistantbusiness development general manager Feilim Mackle. Mackle used to workunder Arthur in the direct-sales division.Arthur&#39s retirement will bring about a raft of new appointments as […]

Sub-prime lendertops 1bn

Sub-prime lender igroup says it has become the first non-conformist lenderto complete mortgage business over 1bn.The company, formerly known as Ocwen UK, was launched in July 1998.Chief executive officer Joseph Dlutowski says: “The whole sector isenjoying huge growth because ourselves and other lenders offer innovativeand affordable products that are attractive to people, many of themprofessionals, […]

Fleming Asset Management…

Fleming Asset Management has introduced an offshore global sciences fundto capita^_lise on changing demographics.It says the sector is changing rapidly as a result of an ageing worldpopulation and the need for an ever inc^_rea^_sing number of drugs tocombat existing and new diseases.The launch, revealed in MM last month, will form part of its flagship fundrange […]

Thumbnail

Employer iPMI responsibilities could continue to escalate, says Jelf

New laws in Dubai will put the burden of providing international private medical insurance (iPMI) firmly on the shoulders of the employer in order to maintain the country’s leading healthcare facilities. With 10,000 UK nationals having moved to the country since 2007 and only 16.5 per cent of the total 8.2 million people living there being Emiratis, Jelf Employee Benefits believes this move was inevitable and employer responsibilities could continue to escalate in future.

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment